Compared to other KRAS-driven diseases like lung adenocarcinoma and colorectal cancer, pancreatic cancer has a higher prevalence of G12R, consistent with MAPK being the dominant signaling pathway driving pancreatic cancer [36,37]. Here, KRAS is linked to lung adenocarcinoma.